Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 29% ± 13% | |
secretory cell | 7 studies | 41% ± 16% | |
epithelial cell | 6 studies | 44% ± 11% | |
basal cell | 6 studies | 35% ± 16% | |
respiratory goblet cell | 4 studies | 30% ± 9% | |
squamous epithelial cell | 4 studies | 65% ± 22% | |
club cell | 3 studies | 28% ± 8% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 32% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 772.59 | 328 / 328 | 94% | 75.52 | 168 / 178 |
lung | 94% | 511.93 | 541 / 578 | 89% | 44.78 | 1030 / 1155 |
prostate | 91% | 1437.58 | 224 / 245 | 89% | 21.35 | 446 / 502 |
thymus | 100% | 534.96 | 651 / 653 | 74% | 17.32 | 448 / 605 |
stomach | 75% | 650.94 | 268 / 359 | 87% | 35.38 | 250 / 286 |
bladder | 57% | 412.76 | 12 / 21 | 90% | 56.20 | 452 / 504 |
breast | 59% | 464.45 | 273 / 459 | 84% | 21.10 | 934 / 1118 |
esophagus | 43% | 2974.26 | 626 / 1445 | 90% | 60.36 | 164 / 183 |
kidney | 100% | 1094.78 | 89 / 89 | 5% | 1.11 | 47 / 901 |
intestine | 12% | 31.96 | 112 / 966 | 93% | 41.37 | 492 / 527 |
uterus | 12% | 170.06 | 21 / 170 | 83% | 73.06 | 379 / 459 |
tonsil | 0% | 0 | 0 / 0 | 93% | 60.08 | 42 / 45 |
ovary | 2% | 2.84 | 3 / 180 | 73% | 19.22 | 312 / 430 |
skin | 67% | 282.59 | 1216 / 1809 | 5% | 0.90 | 23 / 472 |
liver | 25% | 43.13 | 56 / 226 | 13% | 7.85 | 51 / 406 |
brain | 13% | 29.60 | 335 / 2642 | 0% | 0 | 0 / 705 |
adrenal gland | 1% | 1.53 | 2 / 258 | 1% | 0.45 | 3 / 230 |
adipose | 2% | 5.38 | 22 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 3.57 | 6 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 1.94 | 1 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.26 | 2 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.01 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.24 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0010952 | Biological process | positive regulation of peptidase activity |
GO_0005615 | Cellular component | extracellular space |
GO_0016504 | Molecular function | peptidase activator activity |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | PRSS22 |
Protein name | Brain-specific serine protease 4 (BSSP-4) (EC 3.4.21.-) (Serine protease 22) (Serine protease 26) (Tryptase epsilon) Serine protease 22 |
Synonyms | BSSP4 PRSS26 UNQ302/PRO343 SP001LA |
Description | FUNCTION: Preferentially cleaves the synthetic substrate H-D-Leu-Thr-Arg-pNA compared to tosyl-Gly-Pro-Arg-pNA. . |
Accessions | ENST00000161006.8 I3L116 ENST00000645000.2 ENST00000576381.1 ENST00000571228.1 ENST00000642189.2 Q9GZN4 I3L147 |